Strumenti personali
Tu sei qui: Portale → CHE COS'E' IL VII P.Q. → COOPERATION → bandi salute
Accedi


Hai dimenticato la tua password?
Accedi

 

bandi salute

Scadenze: BANDO A: 19 Aprile 2007; BANDO B: 18 Settembre 2007

 Sono stati pubblicati due inviti a presentare proposte per il Tema 1 SALUTE del programma specifico Cooperation, rispettivamente:


BANDO A - FP7-HEALTH-2007-A - Scadenza 19 Aprile 2007, alle 17.00 ora locale di Bruxelles. Bilancio: il bilancio indicativo allocato per il presente invito ammonta a 628 milioni di euro


BANDO B - FP7 -HEALTH - 2007 - B - L'invito non è ancora uscito. Si prevede che il bando sarà pubblicato il 4 Maggio 2007 con scadenza 18 Settembre 2007, alle 17.00 ora locale di Bruxelles.

 

ATTENZIONE: i due bandi contengono tematiche differenti.

La tematica 1 Salute stimola e sostiene le attività di ricerca biomedica di base multidisciplinare. In tale ambito la collaborazione europea è essenziale per sfruttare il potenziale della post genomica e le sue applicazioni nel campo della salute.

Il Tema contribuisce a accrescere la competitività europea nei settori delle biotecnologie e le tecnologie per la salute settori in cui è fondamentale il ruolo svolto dalle Piccole e Medie Imprese e delle industrie farmaceutiche. Sono attesi progressi nello sviluppo di norme e standards per terapie d'avanguardia e contributi alla soluzione di problemi nel campo della salute a livello globale (es. la resistenza antimicrobica, AIDS, malaria, tubercolosi, pandemie emergenti), sviluppo di metodi alternativi alla sperimentazione animale nella ricerca biomedica (c.d The Three R Principle).

La tematica Salute è caratterizzata da forti sinergie e complementarietà con altri temi in particolare con: Tema 2 - Alimentazione, Agricoltura, Pesca e Biotecnologie; Tema 3- Tecnologie per l'informazione e comunicazione; tema 4: Nanoscienze, Nanotecnologie, Materiali e nuove tecniche di produzione; tema 6 Ambiente. L'invito prevede inoltre la possibilità di presentare proposte di azioni orizzontali nell'ambito dell'ottimizzazione dell'assistenza sanitaria ai cittadini europei.

ATTENZIONE: il Workprogramme a pag. 6 specifica esattamente gli ambiti di ricerca sinergici-complementari con le tematiche citate sopra.


CONTRIBUTO COMUNITARIO - Per le università, enti pubblici no-profit, organismi di ricerca e piccole e medie imprese i costi eligibili saranno cofinanziati nelle seguenti proporzioni: attività di ricerca e sviluppo tecnologico: 75%; attività dimostrative: 50%; attività di gestione: 100%; altre attività: 100%.  Il CNR, per il calcolo dei costi indiretti (denominati anche overheads oppure spese generali) utilizza il sistema Simplified method : i costi indiretti vanno calcolati nella misura 86,96% del costo del personale di ricerca.(Circolare CNR n. 14/2007 del 17/5/2007 che aggiorna la circolare 28/2006 fino a tale data la percentuale era pari al 87,6% del costo del personale)


PRESENTAZIONE DELLE PROPOSTE E MATERIALE DI SUPPORTO - I progetti devono essere presentati in un'unica fase. Il testo dell'invito, la guida per il proponente, il Workprogramme e altre informazioni utili sono disponibili on line suo CORDIS rispettivamente ai seguenti indirizzi:

 
* FP7-HEALTH-2007-A –

http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction=UserSite.CooperationDetailsCallPage&call_id=10

* FP7 -HEALTH - 2007 - B - Direttamente nel Workprogramme disponibile on-line all'indirizzo citato sopra

 

MODALITÀ DI VALUTAZIONE - Si sottolinea le proposte dovranno rispettare i seguenti criteri/requisiti pena l'ineligibilità del progetto stesso:

 
- Per i progetti mirati di medie o piccole dimensioni non potrà essere richiesto un contributo comunitario superiore ai 3 milioni di euro a meno che per il tema prescelto il workprogramme dia diversa indicazione

-Per grandi progetti integrati il contributo comunitario richiesto dovrà essere superiore ai 6 milioni di euro ma non dovrà superare i 12 milioni di euro


- Per i progetti mirati di piccole o medie dimensioni dedicati alle Piccole e Medie Imprese 40% del contributo comunitario richiesto deve essere conferito alle stesse.

 

AZIONI E PARTENARIATO


* Progetti di collaborativi - Devono partecipare minimo 3 persone giuridiche pubbliche/private con sede negli Stati Membri della UE, Paesi Candidati di tre differenti paesi.

* Progetti collaborativi dedicati ai paesi partner della cooperazione internazionale (SICA) - Devono partecipare almeno 4 persone giuridiche pubbliche/private di cui: 2 devono avere sede in due differenti Stati Membri della UE o Paesi Candidati Associati, gli altri 2 devono provenire da due differenti paesi partner della cooperazione internazionale

* Azioni di coordinamento e supporto per la tipologia di coordinamento - Devono partecipare minimo 3 persone giuridiche pubbliche/private con sede negli Stati Membri della UE, Paesi Candidati di tre differenti paesi.
* Azioni di coordinamento e supporto tipologia di supporto -Deve partecipare minimo una persona giuridica pubblica/privata.
* Attività di ricerca dedicate alle Piccole e Medie Imprese - Devono partecipare minimo 3 persone giuridiche pubbliche/private con sede negli Stati Membri della UE, Paesi Candidati di tre differenti paesi.

 

SINTESI DELLE TEMATICHE DEI BANDI APERTI

1) BANDO FP7-HEALTH-2007-A

Descrizione sintetica delle tematiche

Scadenza - 19 Aprile 2007, alle 17.00 ora locale di Bruxelles

Bilancio - Il bilancio indicativo allocato per il presente invito ammonta a 628 milioni di euro

TEMATICHE

1. BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH - BILANCIO INDICATIVO ALLOCATO: 138 MILIONI DI EURO

1.1. HIGH-THROUGHPUT RESEARCH
1.1. HEALTH-2007-1.1-1: Unifying human and model organism genetic variation databases. Collaborative project (Large scale integrating project)
1.1. HEALTH-2007-1.1-2: Temporal and spatial proteomics to study biological processes relevant to human health.
Collaborative project (Large scale integrating project)
1.1. HEALTH-2007-1.1-3: Groundbreaking techniques for DNA sequencing and genotyping. Collaborative project (Large scale integrating project)

1.2. DETECTION, DIAGNOSIS AND MONITORING
1.2. HEALTH-2007-1.2-1: Development of a hybrid imaging system. Collaborative project (Small or medium-scale focused research project)
1.2. HEALTH-2007-1.2-2: Novel optical methodologies for detection, diagnosis and monitoring of disease or disease-related processes. Collaborative project (Small or medium-scale focused research project)
1.2. HEALTH-2007-1.2-3: Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy. Collaborative project (Large scale integrating project)
1.2. HEALTH-2007-1.2-4: In vivo image-guidance for cell therapy. Collaborative project (Large scale integrating project)

1.3. PREDICTING SUITABILITY, SAFETY AND EFFICACY OF THERAPIES

1.3. HEALTH-2007-1.3-1: Novel alternative testing strategies for use in pharmaceutical discovery and development.
Collaborative project (Large scale integrating project)
1.3.HEALTH-2007-1.3-2: Bottlenecks in reduction, refinement and replacement of animal testing in pharmaceutical discovery and development. Coordination and support action (Coordination or support action)
1.3.HEALTH-2007-1.3-3: Promotion, development, validation, acceptance and implementation of QSARs (quantitative structureactivity relationship) for toxicology. Collaborative project (Small or medium-scale focused research
project)
1.3.HEALTH-2007-1.3-4: Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. Collaborative project (Small or medium-scale focused research project)
1.3. HEALTH-2007-1.3-5: In silico modelling for ADMET outcomes. Collaborative project (Largescale integrating project)

1.4. INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS

1.4. HEALTH-2007-1.4-1: Development and production of new generation antibodies.
Collaborative project (Small or medium-scale focused research project)
1.4. HEALTH-2007-1.4-2: Innovative approaches for the development of vaccines for young children.
Collaborative project (Small or medium-scale focused research project)
1.4. HEALTH-2007-1.4-3: Immunotherapy of human food allergies. Collaborative project (Small or
medium-scale focused research project)

2. TRANSLATING RESEARCH FOR HUMAN HEALTH - BILANCIO INDICATIVO ALLOCATO: 472 MILIONI DI EURO

2.1. INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS
BIOLOGY

2.1.1. Large scale data gathering

2.1.1.HEALTH-2007-2.1.1-1: Networking biobanking initiatives across Europe: developing standards and norms for existing and future human sample biobanks.
Collaborative project (Largescale integrating project)
2.1.1.HEALTH-2007-2.1.1-2: Molecular epidemiological studies in existing well characterised European (and/or other) population cohorts. Collaborative project (Large scale integrating project)
2.1.1. HEALTH-2007-2.1.1-3: Comparative studies of genetic variation in humans: towards a reference population in Europe. Collaborative project (Large scale integrating project)
2.1.1. HEALTH-2007-2.1.1-4: Characterisation and variability of the microbial communities in the Human Body
Collaborative project (Large scale integrating project)
2.1.1.HEALTH-2007-2.1.1-5: Structure-function analysis of membrane-transporters and channels for the identification of potential drug target sites. Collaborative project (Large scale integrating project)
2.1.1. HEALTH-2007-2.1.1-6: High throughput analysis of lipids and lipid-protein interactions. Collaborative project (Large scale integrating project)
2.1.1. HEALTH-2007-2.1.1-7: Genome-wide association studies in mammalian non-rodent models for the identification of genes relevant to human health and disease. Collaborative project (Large scale integrating project)

2.1.2. Systems biology

2.1.2. HEALTH-2007-2.1.2-1: A system approach to eukaryotic unicellular organism biology. Collaborative project (Large scale integrating project)
2.1.2. HEALTH-2007-2.1.2-2: Modelling of T-cell activation. Collaborative project (Large scale integrating project)
2.1.2. HEALTH-2007-2.1.2-3: Fundamental approaches to stem cell differentiation. Collaborative project (Large scale integrating project)
2.1.2.HEALTH-2007-2.1.2-4: Developing an integrated in vitro, in vivo and systems biology modelling approach to understanding apoptosis in the context of health and disease Collaborative project (Large scale integrating project)

2.2. RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING
2.2.1. Brain and brain-related diseases

2.2.1. HEALTH-2007-2.2.1-1: Stroke and mechanisms underlying ischemic brain damage.
Collaborative project (Large scale integrating project)
2.2.1. HEALTH-2007-2.2.1-2: Coding in neuronal assemblies. Collaborative project (Small or medium-scale focused research project)
2.2.1. HEALTH-2007-2.2.1-3: Neurobiology of anxiety disorders. Collaborative project (Small or medium-scale focused research project)
2.2.1. HEALTH-2007-2.2.1-4: Memory loss: underlying mechanisms and therapy. Collaborative project (Small or
medium-scale focused research project)
2.2.1. HEALTH-2007-2.2.1-5: From basic spinal mechanisms to spinal cord disease and trauma.
Collaborative project (Small or medium-scale focused research project)
2.2.1. HEALTH-2007-2.2.1-6: Neuron-glia interactions in health and disease. Collaborative project (Small or
medium-scale focused research project)

2.2.2. Human development and ageing
2.2.2. HEALTH-2007-2.2.2-1: Novel approaches to reconstitute normal immune function at old age.
Collaborative project (Large scale integrating project)
2.2.2. HEALTH-2007-2.2.2-2: Termination of developmental processes and their reactivation in adult life.
Collaborative project (Largescale integrating project)
2.2.2. HEALTH-2007-2.2.2-3: Biomarkers of ageing. Collaborative project (Largescale integrating project)
2.2.2. HEALTH-2007-2.2.2-4: Increasing the participation of elderly in clinical trials.
Coordination and support action (Coordination or support action)
2.2.2. HEALTH-2007-2.2.2-5: Research on human development and/or healthy ageing across the EU
Coordination and support action (Coordination or support action)

2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH

2.3.1 Anti-microbial drug resistance including fungal pathogens

2.3.2. HIV/AIDS, malaria and tuberculosis

2.3.2. HEALTH-2007-2.3.2-1: HIV/AIDS Drug Discovery and Preclinical Development.
Collaborative project (Small or medium-scale focused research project)
2.3.2. HEALTH-2007-2.3.2-2: Highly innovative approaches for research into host-pathogen interaction in tuberculosis.
Collaborative project (Small or medium-scale focused research project)
2.3.2.HEALTH-2007-2.3.2-3: Development of fast tests for the diagnosis of Multi-Drug-Resistant strains of HIV, malaria and tuberculosis and of latent tuberculosis infection (LTBI). Collaborative project (Small or medium-scale focused research project)
2.3.2. HEALTH-2007-2.3.2-4: Addressing knowledge gaps in pregnancy malaria.
Collaborative project (Small or medium-scale focused research project)
2.3.2. HEALTH-2007-2.3.2-5: Paediatric formulations of drugs against HIV/AIDS, malaria and tuberculosis.
Coordination and support action (Coordination or support action)
2.3.2. HEALTH-2007-2.3.2-6: New HIV Vaccines inducing broadly reactive neutralising antibodies.
Collaborative project (Large scale integrating project)

2.3.3. Potentially new and re-emerging epidemics
2.3.3. HEALTH-2007-2.3.3-1: Development of broadly protective influenza vaccine candidates. Collaborative project (Small or medium-scale focused research project)
2.3.3. HEALTH-2007-2.3.3-2: Identifying immunological mechanisms of protection for influenza vaccines.
Collaborative project (Small or medium-scale focused research project)
2.3.3. HEALTH-2007-2.3.3-3: Standardisation of immunological assays including surrogate markers for evaluation of new influenza vaccines in clinical trials. Coordination and support action (Coordination or support action)
2.3.3. HEALTH-2007-2.3.3-4: Innovative point-of-care diagnostic tests for influenza.
Collaborative project (Small or medium-scale focused research project targeted to SMEs)
2.3.3. HEALTH-2007-2.3.3-5: Development of additional treatment strategies for patients suffering from highly pathogenic influenza. Collaborative project (Small or medium-scale focused research project)
2.3.3. HEALTH-2007-2.3.3-6: Development of pandemic influenza containment and mitigation strategies.
Collaborative project (Small or medium-scale focused research project)
2.3.3. HEALTH-2007-2.3.3-7: Supporting highly innovative interdisciplinary research on influenza.
Collaborative project (Small or medium-scale focused research project)
2.3.3. HEALTH-2007-2.3.3-8: Influenza research in collaboration with Asian partners. SICA: Collaborative project (Small or medium-scale focused research project)

2.3.4. Neglected infectious diseases
2.4. TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES
2.4.1. Cancer
2.4.1. HEALTH-2007-2.4.1-1: Translating the knowledge on noncoding RNAs linked to the aetiology of cancer into novel
diagnosis and therapy strategies. Collaborative project (Small or medium-scale focused research project)
2.4.1.HEALTH-2007-2.4.1-2: Translating clinical 'omics'-technology (genomics, proteomics, metabolomics) into innovative cancer biomarkers aiding in early diagnosis, prognosis and treatment selection of cancer patients.
Collaborative project (Small or medium-scale focused research project)
2.4.1. HEALTH-2007-2.4.1-3: Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer.
Collaborative project (Small or medium-scale focused research project)
2.4.1. HEALTH-2007-2.4.1-4: Novel cancer screening methods. Collaborative project (Small or medium-scale focused research project)
2.4.1. HEALTH-2007-2.4.1-5: Optimising research on end of life care of cancer patients. Coordination and support
action (Coordination action)
2.4.1. HEALTH-2007-2.4.1-6: Understanding and fighting metastasis. Collaborative project (Small or
medium-scale focused research project)
2.4.1. HEALTH-2007-2.4.1-7: Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy. Collaborative project (Small or medium-scale focused research project)
2.4.1. HEALTH-2007-2.4.1-8: Developing high-throughput bioassays and models for human cancers in lower species.
Collaborative project (Small or medium-scale focused research project)

2.4.2. Cardiovascular disease
2.4.2. HEALTH-2007-2.4.2-1: Molecular basis of the inflammatory response and associated vascular remodelling in arteriosclerosis. Collaborative project (Largescale integrating project)
2.4.2. HEALTH-2007-2.4.2-2: Vascular remodelling in aneurismal disease. Collaborative project (Large scale
integrating project)
2.4.2. HEALTH-2007-2.4.2-3: Combating stroke. Collaborative project (Large scale integrating project)

2.4.3. Diabetes and obesity
2.4.3. HEALTH-2007-2.4.3-1: Early processes in the pathogenesis of type 1 diabetes and strategies for early prevention.
Collaborative project (Small or medium-scale focused research project)
2.4.3. HEALTH-2007-2.4.3-2: Combined forms of diabetes in children. Collaborative project (Small or
medium-scale focused research project)
2.4.3. HEALTH-2007-2.4.3-3: Insulin resistance as a key factor in the development of diabetes and metabolic syndrome. Collaborative project (Small or medium-scale focused research project)
2.4.3. HEALTH-2007-2.4.3-4: Pathophysiological mechanisms related to excess fat. Collaborative project (Small or
medium-scale focused research project)
2.4.3. HEALTH-2007-2.4.3-5: A road-map for diabetes research. Coordination and support action (Coordination or support action)

2.4.4. Rare diseases
2.4.4. HEALTH-2007-2.4.4-1: Natural course and pathophysiology of rare diseases. Collaborative project (Small or
medium-scale focused research project)
2.4.4. HEALTH-2007-2.4.4-2: Research capacity-building in the field of rare diseases. Coordination and support
action (Coordination or support action)

2.4.5. Other chronic diseases
2.4.5. HEALTH-2007-2.4.5-1: Osteoarthritis. Collaborative project (Large scaleintegrating project)
2.4.5. HEALTH-2007-2.4.5-2: Inflammatory bowel disease.Collaborative project (Small or medium-scale focused research project)
2.4.5. HEALTH-2007-2.4.5-3: Osteoporosis: signalling pathways in bone formation and homeostasis.
Collaborative project (Small or medium-scale focused research project)
2.4.5. HEALTH-2007-2.4.5-4: Genetic factors of Osteoporosis. Collaborative project (Small or medium-scale focused research project)
2.4.5. HEALTH-2007-2.4.5-5: Intervertebral disc degeneration: prevention and repair.Collaborative project (Small or medium-scale focused research project)
2.4.5. HEALTH-2007-2.4.5-6: Innovative concepts in chronic obstructive pulmonary disease pathogenesis (COPD).
Collaborative project (Small or medium-scale focused research project)
2.4.5. HEALTH-2007-2.4.5-7: Hearing impairment and degeneration. Coordination and support action (Coordination or support action)
2.4.5. HEALTH-2007-2.4.5-8: Impairment of touch and proprioception at old age. Coordination and support
action (Coordination or support action)
2.4.5. HEALTH-2007-2.4.5-9: Visual impairment and degeneration. Coordination and support action (Coordination or support action)

4. OTHER ACTIONS ACROSS THE HEALTH THEME - BILANCIO INDICATIVO ALLOCATO: 18 MILIONI DI EURO DI CUI 6 MILIONI DI EURO PER LA COOPERAZIONE INTERNAZIONALE

4.1. COORDINATION AND SUPPORT ACTIONS ACROSS THE THEME

4.1.HEALTH-2007-4.1-1: Reinforcing the network of National Contact Points (NCP) for the Seventh Framework Programme under Health Theme by promoting trans-national co-operation. Coordination and support
action (Coordination or support action)
4.1.HEALTH-2007-4.1-2: Promoting participation of hightechnology research intensive SMEs, operating in the biomedical engineering and other medical technology sectors relevant to Health Theme. Coordination and support action (Support action)
4.1. HEALTH-2007-4.1-3: Assessment and valorisation of project outcome for high-technology and research intensive SME participating to Framework Programmes of Research in the healthcare sector. Coordination and support
action (Support action)
4.1. HEALTH-2007-4.1-4: Identifying patients' needs in the clinical trials context.
Coordination and support action (Coordination or support action)
4.1. HEALTH-2007-4.1-5: Science communication actions. Coordination and support action (Support action)
4.1. HEALTH-2007-4.1-6: Initiatives to foster dialogue and debate on heath research issues of interest to the public.
Coordination and support action (Support action)
4.1. HEALTH-2007-4.1-7: Studies on impact of EU legislations on health research and related developments and applications. Coordination and support action (Support action)

4.2. RESPONDING TO EU POLICY NEEDS
4.2. HEALTH-2007-4.2-3: Research to assess the economic dimension of occupational health and safety.
Coordination and support action (Support action)
4.2. HEALTH-2007-4.2-4: Health statistics and rare events. Collaborative project (Small or medium-scale focused research project)

 

BANDO FP7-HEALTH-2007-B
Data attesa di pubblicazione: 4 Maggio 2007
Scadenza: 18 Settembre 2007, alle 17.00 ora locale di Bruxelles
Bilancio indicativo: non ancora disponibile

TEMATICHE

1. BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH
1.1. HIGH-THROUGHPUT RESEARCH
1.1.HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for highthroughput research Collaborative project (Small or medium-scale focused research project targeted to SMEs)
1.2. DETECTION, DIAGNOSIS AND MONITORING
1.2. HEALTH-2007-1.2-5: Standardisation and improvement of preanalytical procedures for in vitro diagnostics.
Collaborative project (Largescale integrating project)
1.2.HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation. Collaborative project (Small or medium-scale focused research
project)
1.3. PREDICTING SUITABILITY, SAFETY AND EFFICACY OF THERAPIES
1.4. INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS
1.4. HEALTH-2007-1.4-4: Development of emerging gene therapy tools and technologies for clinical application.
Collaborative project (Largescale integrating project)
1.4. HEALTH-2007-1.4-5: Gene therapy tools targeting the central nervous system.
Collaborative project (Small or medium-scale focused research project)
1.4. HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies. Collaborative project (Large scale integrating project)
1.4. HEALTH-2007-1.4-7: Development of stem cell culture conditions.
Collaborative project (Small or medium-scale focused research project)
1.4. HEALTH-2007-1.4-8: Stem cells for kidney regeneration. Collaborative project (Small or
medium-scale focused research project)
1.4. HEALTH-2007-1.4-9: Adding value to EU stem cell therapy research: scientific communication and future perspectives. Coordination and support action (Coordination or support action)

2. TRANSLATING RESEARCH FOR HUMAN HEALTH

2.1. INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS
BIOLOGY
2.1.1. Large scale data gathering
2.1.2. Systems biology
2.1.2.HEALTH-2007-2.1.2-5: Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and diseases. Collaborative project (Small or medium-scale focused research project)
2.1.2. HEALTH-2007-2-1-2-6: Coordination and Support Actions in large-scale data gathering and systems biology.
Coordination and support action (Coordination or support action)
2.1.2. HEALTH-2007-2.1.2-7: Traditional Chinese Medicine in postgenomic era. SICA: Coordination and support action (Coordination or support action)

2.2. RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING
2.2.1. Brain and brain-related diseases
2.2.1. HEALTH-2007-2.2.1-7: Restorative approaches for therapy of neurodegenerative diseases.
Collaborative project (Small or medium-scale focused research project)
2.2.1. HEALTH-2007-2.2.1-8: From mood disorders to experimental models.
Collaborative project (Largescale integrating project)
2.2.1. HEALTH-2007-2.2.1-9: Neuronal mechanisms of vision and related diseases.
Collaborative project (Small or medium-scale focused research project)
2.2.1.HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders. SICA: Collaborative project
(Small or medium-scale focused research project)
2.2.2. Human development and ageing

2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH
2.3.1. Anti-microbial drug resistance including fungal pathogens
2.3.1. HEALTH-2007-2.3.1-1: Novel targets for drugs against Gram negative bacteria.
Collaborative project (Small or medium-scale focused research project)
2.3.1. HEALTH-2007-2.3.1-2: Host-pathogen interactions in infections by Streptococcus pneumoniae.
Collaborative project (Small or medium-scale focused research project)
2.3.1.HEALTH-2007-2.3.1-3: An integrated platform for development and clinical evaluation of point-of-care diagnostic devices for microbial detection, antibiotic susceptibility determination and biomarkers. Collaborative project (Largescale integrating project)
2.3.1. HEALTH-2007-2.3.1-4: Molecular epidemiology to control nosocomial and community spreading of highly virulent multidrug resistant strains of bacterial pathogens. Collaborative project (Small or medium-scale focused research project)
2.3.1. HEALTH-2007-2.3.1-5: Health and economic cost of antimicrobial resistance.
Coordination and support action (Coordination or support action)
2.3.1. HEALTH-2007-2.3.1-6: Conference on genetic and biochemical tools for post-genomic physiological analysis of Staphylococcus, in particular MRSA. Coordination and support action (Coordination or support action)
2.3.2. HIV/AIDS, malaria and tuberculosis
2.3.2. HEALTH-2007-2.3.2-7: Network on HIV and anti-HIV drug resistance. Collaborative project (Largescale
integrating project)
2.3.2. HEALTH-2007-2.3.2-8: HIV and Hepatitis co-infection. Coordination and support
action (Coordination or support action)
2.3.2. HEALTH-2007-2.3.2-9: Blocking the transmission of malaria: the mosquito vector target.
Collaborative project (Small or medium-scale focused research project)
2.3.2. HEALTH-2007-2.3.2-10: European network for study and clinical management of TB drug resistance.
Collaborative project (Largescale integrating project)
2.3.2. HEALTH-2007-2.3.2-11: Support platform for the development of PRD vaccines Coordination and support
action (Coordination or support action)
2.3.2. HEALTH-2007-2.3.2-12: Highly innovative research in HIV/AIDS, malaria and tuberculosis between Indian and
European partners. SICA: Collaborative project (Small or medium-scale focused research project)
2.3.2. HEALTH-2007-2.3.2-13: Coordination of European research activities with global initiatives, including Public-Private Partnerships. SICA: Coordination and support action (Coordination or support action)
2.3.2.HEALTH-2007-2.3.2-14: Next generation of researchers for HIV/AIDS, malaria, tuberculosis and neglected infectious diseases. SICA: Coordination and support action (Coordination or support action)
2.3.3. Potentially new and re-emerging epidemics
2.3.3. HEALTH-2007-2.3.3-9: Strengthening research on prediction, identification, modelling and surveillance of newly emerging infectious diseases in humans. Collaborative project (Large scale integrating project)
2.3.3. HEALTH-2007-2.3.3-10: Definition of research needs and priorities in Europe in the area of Emerging Infectious
Epidemics. Coordination and support action (Coordination or support action)
2.3.4. Neglected infectious diseases
2.3.4. HEALTH-2007-2.3.4-1: Development of new tools to control infections due to parasites of the Trypanosomatidae family. SICA: Collaborative project (Small or medium-scale focused research project)
2.3.4. HEALTH-2007-2.3.4-2: Development of a Leishmania vaccine. SICA: Collaborative project (Small or medium-scale focused research project)
2.3.4. HEALTH-2007-2.3.4-3: Bioprospecting for drug leads SICA: Collaborative project (Small or medium-scale
focused research project)

2.4. TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES
2.4.1. Cancer
2.4.1. HEALTH-2007-2.4.1-9: Innovative combination clinical trials for multimodal cancer therapy.
Collaborative project (Largescale integrating project)
2.4.1. HEALTH-2007-2.4.1-10: Role of inflammation in tumour initiation and progression. Collaborative project (Largescale integrating project)
2.4.1. HEALTH-2007-2.4.1-11: Epidemiology of gene-environment interactions involved in carcinogenesis.
Collaborative project (Largescale integrating project)
2.4.1. HEALTH-2007-2.4.1-12: Translating the hypoxic tumour microenvironment. Collaborative project (Large scale
integrating project)
2.4.1.HEALTH-2007-2.4.1-14: Studying cancer aetiology in Latin America.SICA: Collaborative project
(Small or medium-scale focused research project)
2.4.2. Cardiovascular disease
2.4.2. HEALTH-2007-2.4.2-4: Congenital pathologies affecting the heart. Collaborative project (Small or
medium-scale focused research project)
2.4.2. HEALTH-2007-2.4.2-5: Cell therapies for the treatment of heart ischemia. Collaborative project (Small or
medium-scale focused research project)
2.4.2. HEALTH-2007-2.4.2-6: Organ imaging in CVD. Collaborative project (Small or medium-scale focused research
project)
2.4.2. HEALTH-2007-2.4.2-7: Integrating pharmacogenomic approaches into the treatment of CVD.
Collaborative project (Small or medium-scale focused research project)
2.4.3. Diabetes and obesity
2.4.3. HEALTH-2007-2.4.3-6: Nutritional signals and the development of new diabetes/obesity therapeutic agents.
Collaborative project (Small or medium-scale focused research project targeted to SMEs)
2.4.3. HEALTH-2007-2.4.3-7: Markers and treatment for diabetic neuropathy complications. Collaborative project (Small or medium-scale focused research project)
2.4.3. HEALTH-2007-2.4.3-8: Geno- and phenotypical differentiation of type 2 subjects and monogenic subjects.
Collaborative project (Small or medium-scale focused research project)
2.4.3. HEALTH-2007-2.4.3-9: Use of beta cell imaging in diabetes mellitus. Collaborative project (Small or
medium-scale focused research project)
2.4.4. Rare diseases
2.4.5. Other chronic diseases
2.4.5. HEALTH-2007-2.4.5-10: Understanding and combating age related muscle weakness. Collaborative project (Largescale integrating project)
2.4.5. HEALTH-2007-2.4.5-11: Translational research aiming for a treatment of urinary incontinence. Collaborative project (Small or medium-scale focused research project)
2.4.5. HEALTH-2007-2.4.5-12: Early processes in the pathogenesis of chronic inflammatory diseases. Collaborative project (Largescale integrating project)

3. OPTIMISING DELIVERY OF HEALTH CARE TO EUROPEAN CITIZENS

3.1. TRANSLATING THE RESULTS OF CLINICAL RESEARCH OUTCOME INTO CLINICAL PRACTICE
INCLUDING BETTER USE OF MEDICINES, AND APPROPRIATE USE OF BEHAVIOURAL AND
ORGANISATIONAL INTERVENTIONS AND NEW HEALTH THERAPIES AND TECHNOLOGIES
3.1. HEALTH-2007-3.1-1: Implementation of research into healthcare practice. Collaborative project (Small or
medium-scale focused research project)
3.1. HEALTH-2007-3.1-2: Self-medication and patient safety. Collaborative project (Small or medium-scale focused research project)
3.1. HEALTH-2007-3.1-3: Patient Safety Research Network. Coordination and support action (Coordination action)
3.1. HEALTH-2007-3.1-4: Improving clinical decision making. Collaborative project (Small or medium-scale focused research project)
3.1. HEALTH-2007-3.1-5: Better use of medicines. Collaborative project (Small or medium-scale focused research
project)
3.1. HEALTH-2007-3.1-6: Continuity of clinical care. Collaborative project (Small or medium-scale focused research
project)
3.1. HEALTH-2007-3.1-7: Patient self-management of chronic disease. Collaborative project (Small or
medium-scale focused research project)

3.2. QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTH CARE SYSTEMS INCLUDING TRANSITIONAL
HEALTH SYSTEMS
3.2. HEALTH-2007-3.2-1: Evaluation of disease management programmes. Collaborative project (Small or medium-scale focused research project)
3.2. HEALTH-2007-3.2-2: Health systems and long term care of the elderly. Collaborative project (Small or medium-scale focused research project)
3.2. HEALTH-2007-3.2-3: Mobility of health professionals. Collaborative project (Small or medium-scale focused research project)
3.2. HEALTH-2007-3.2-4: Health care human resource planning in nursing. Collaborative project (Small or
medium-scale focused research project)
3.2. HEALTH-2007-3.2-5: Clinician working time and patient safety. Collaborative project (Small or
medium-scale focused research project)
3.2. HEALTH-2007-3.2-6: Health outcome measures and population ageing. Collaborative project (Small or
medium-scale focused research project)
3.2. HEALTH-2007-3.2-7: Trends of population health. Collaborative project (Small or medium-scale focused research
project)
3.2. HEALTH-2007-3.2-8: European system of Diagnosis-related groups (DRG). Collaborative project (Small or
medium-scale focused research project)

3.3. ENHANCED HEALTH PROMOTION AND DISEASE PREVENTION
3.3. HEALTH-2007-3.3-1: Promoting healthy behaviour in children and adolescents. Collaborative project (Small or
medium-scale focused research project)
3.3. HEALTH-2007-3.3-2: Interventions addressing the gradient of health inequalities.
Collaborative project (Small or medium-scale focused research project)
3.3. HEALTH-2007-3.3-3: Public health interventions addressing the abuse of alcohol. Collaborative project (Small or
medium-scale focused research project)
3.3. HEALTH-2007-3.3-4: Evaluation of suicide prevention strategies across and within European countries.
Collaborative project (Small or medium-scale focused research project)
3.3. HEALTH-2007-3.3-5: Improve vaccination coverage. Collaborative project (Small or medium-scale focused research project)

3.4. HORIZONTAL COORDINATION AND SUPPORT ACTIONS ACROSS "OPTIMISING THE DELIVERY OF
HEALTH CARE TO EUROPEAN CITIZENS"
3.4. HEALTH-2007-3.4-1: Disease networks of centres of reference. Coordination and support action (Support action)
3.4. HEALTH-2007-3.4-2: Effectiveness of health investments. Coordination and support action (Support action)
3.4. HEALTH-2007-3.4-3: Patient mobility and access to information.Coordination and support action (Coordination or
support action)
3.4. HEALTH-2007-3.4-4: Brokering research into policy. Coordination and support action (Support action)
3.4. HEALTH-2007-3.4-5: A road-map for ageing research. Coordination and support
action (Coordination or support action)
3.4. HEALTH-2007-3.4-6: Health Services Research conference. Coordination and support action (Support action)
3.4. HEALTH-2007-3.4-7: Mental health research conference. Coordination and support action (Support action)
3.4. HEALTH-2007-3.4-8: Public Health intervention research conference. Coordination and support
action (Support action)

3.5. SPECIFIC INTERNATIONAL COOPERATION ACTIONS FOR HEALTH SYSTEM RESEARCH
3.5 HEALTH-2007-3.5-1: Epidemiological investigations into longterm trends of population health as consequence of socioeconomic transitions, including life-style induced health problems. SICA: Collaborative project (Small or medium-scale focused research project)
3.5 HEALTH-2007-3.5-2: Universal and equitable access to health care and health financing. SICA: Collaborative project (Small or medium-scale focused research project)
3.5 HEALTH-2007-3.5-3: Health care intervention research - optimising hospital care. SICA: Collaborative project
(Small or medium-scale focused research project)
3.5 HEALTH-2007-3.5-4: Health care intervention research -improving pre-natal and maternal care.
SICA: Collaborative project (Small or medium-scale focused research project)

4. OTHER ACTIONS ACROSS THE HEALTH THEME

4.1. COORDINATION AND SUPPORT ACTIONS ACROSS THE THEME

4.1. HEALTH-2007-4.1-8: Promotion and facilitation of international cooperation in areas relevant to the objectives of this Theme. SICA: Coordination and support action (Coordination or support action)

4.2. RESPONDING TO EU POLICY NEEDS

4.2. HEALTH-2007-4.2-1: Adapting off-patent medicines to the specific needs of paediatric populations.
Collaborative project (Small or medium-scale focused research project)
4.2. HEALTH-2007-4.2-2: Relative safety of non-steroidal anti-inflammatory drugs (NSAIDs).
Collaborative project (Small or medium-scale focused research project)
4.2. HEALTH-2007-4.2-5: Effectiveness of fiscal policies for tobacco control in Europe. Collaborative project (Small or medium-scale focused research project)

 

Azioni sul documento
« marzo 2025 »
marzo
lumamegivesado
12
3456789
10111213141516
17181920212223
24252627282930
31